Search Result "A<sub>2A</sub> antagonists"
A2A Adenosine Receptor Antagonists and their Potential in NeurologicalDisorders
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 28 Year: 2022 Page: 4780-4795
Author(s):
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 24 Year: 2022 Page: 4138-4151
Author(s): Stefania Gessi,Kenneth A. Jacobson,Fabrizio Vincenzi,Katia Varani,Pier A. Borea,Stefania Merighi
Adenosine A2A Receptor Antagonists as Positron Emission Tomography (PET) Tracers
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 3 Year: 2014 Page: 312-328
Author(s): S. Khanapur,A. van Waarde,K. Ishiwata,K. L. Leenders,R. A.J.O. Dierckx,P. H. Elsinga
Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Roleof Curcumin, Dopamine Agonist and Adenosine A2A Receptor Antagonist
Journal: Current Aging Science
Volume: 15 Issue: 1 Year: 2022 Page: 65-76
Author(s): Asmaa Fathy Aboul Naser,Wessam Magdi Aziz,Yomna Rashad Ahmed,Wagdy Khalil Bassaly Khalil,Manal Abdel Aziz Hamed
Recent Studies on Serotonin 5-HT2A Receptor Antagonists in MedicinalChemistry: A Last Decades Survey
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 23 Issue: 19 Year: 2023 Page: 1859-1870
Author(s): Jignesh H. Kamadar,D Roza Kumari,Khushal M Kapadiya
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 28 Year: 2016 Page: 3224-3257
Author(s): Sara Redenti,Antonella Ciancetta,Giorgia Pastorin,Barbara Cacciari,Stefano Moro,Giampiero Spalluto,Stephanie Federico
Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 8 Year: 2015 Page: 975-988
Author(s): Jacobus P. Petzer,Anel Petzer
Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimerâs Disease
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 14 Year: 2016 Page: 2064-2071
Author(s): Felix-Martin Werner,Rafael Covenas
The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson's Disease
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 27 Year: 2014 Page: 3188-3210
Author(s): M. Jorg,P.J. Scammells,B. Capuano
Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Journal: Current Drug Therapy
Volume: 10 Issue: 2 Year: 2015 Page: 66-81
Author(s): Felix-Martin Werner,Rafael Coveñas